Lisata Therapeutics Inc. (LSTA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lisata Therapeutics Inc.

    NASDAQ: LSTA · Real-Time Price · USD
    2.57
    0.05 (1.98%)
    At close: Oct 06, 2025, 10:14 AM

    Lisata Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -19.98M -20.84M -54.23M -27.47M
    Depreciation & Amortization
    		 174K 189K 69K 55K
    Stock-Based Compensation
    		 1.65M 2.04M 2.64M 2M
    Other Working Capital
    		 1.02M -550K -608K -603K
    Other Non-Cash Items
    		 -325K -957K 31.18M 2.51M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -873K -462K -831K 647K
    Operating Cash Flow
    		 -19.36M -20.03M -21.17M -22.25M
    Capital Expenditures
    		 n/a n/a -285K -60K
    Cash Acquisitions
    		 -130K n/a -3.32M 54.84K
    Purchase of Investments
    		 -55.69M -98.48M -89.69M -179.78M
    Sales Maturities Of Investments
    		 69.05M 108.58M 122.2M 124.94M
    Other Investing Acitivies
    		 n/a n/a n/a -54.84K
    Investing Cash Flow
    		 13.23M 10.1M 28.91M -54.9M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -274K 64K -267K -224K
    Financial Cash Flow
    		 -206K 385K -224K 85.28M
    Net Cash Flow
    		 -6.38M -9.56M 7.51M 8.13M
    Free Cash Flow
    		 -19.36M -20.03M -21.45M -22.3M

    Add to Watchlist